MedPath

Methylergonovine Maleate

Methylergonovine Maleate Tablets USP A211455

Approved
Approval ID

2fbdc9c4-b9d4-4796-adda-6144bdea0990

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2020

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP.

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methylergonovine Maleate

PRODUCT DETAILS

NDC Product Code17856-3655
Application NumberANDA211455
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 31, 2020
Generic NameMethylergonovine Maleate

INGREDIENTS (11)

METHYLERGONOVINE MALEATEActive
Quantity: 0.2 mg in 1 1
Code: IR84JPZ1RK
Classification: ACTIB
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TARTARIC ACIDInactive
Code: W4888I119H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methylergonovine Maleate - FDA Drug Approval Details